Genotech is a Turkish biotechnology startup, established in 2012, specializing in the production of phytotherapeutic products and dietary supplements. The company's mission is to positively impact human health through its expertise in phytotherapeutics. Genotech has gained recognition for its innovative approach, presenting projects at international scientific conferences and competitions, and securing awards from national competitions.
The team has received support from various platforms, including TÜBİTAK MAM and the TÜSİAD Bu Gençlikte İş Var Ege Camp, where they participated in mentorship programs and continue to work with mentor Filip Minasyan. With a track record of 8 awards and a focus on establishing a significant presence in the dietary supplements field, Genotech is currently directing its efforts towards GENOLIVE, a solution targeting individuals with early-stage liver cancer or those at high risk of liver-related ailments.
As of now, there is no public information available regarding Genotech's last investment or the involved investors. The company operates from its headquarters situated in Turkey. With its vision and ongoing initiatives, Genotech presents an intriguing prospect for potential investors seeking opportunities in the biotechnology and life sciences industries.